tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HURA Stock Latest News

TuHURA Biosciences Advances Clinical Trials and Strengthens Market Position
Company AnnouncementsTuHURA Biosciences Advances Clinical Trials and Strengthens Market Position
1d ago
HURA
TuHURA Biosciences files to sell 4.76M shares of common stock for holders
PremiumThe Fly
TuHURA Biosciences files to sell 4.76M shares of common stock for holders
3d ago
HURA
TuHURA Biosciences included in Russell 3000 and 2000 Indexes
PremiumThe Fly
TuHURA Biosciences included in Russell 3000 and 2000 Indexes
2M ago
HURA
TuHURA Biosciences Completes Acquisition of Kineta, Inc.
PremiumCompany Announcements
TuHURA Biosciences Completes Acquisition of Kineta, Inc.
2M ago
8K
HURA
TuHURA Biosciences Increases Authorized Common Stock Shares
PremiumCompany Announcements
TuHURA Biosciences Increases Authorized Common Stock Shares
2M ago
8K
HURA
Buy Rating for TuHURA Biosciences: Promising Phase 3 Study and Strategic Merger with Kineta Inc.
PremiumRatingsBuy Rating for TuHURA Biosciences: Promising Phase 3 Study and Strategic Merger with Kineta Inc.
2M ago
HURA
TuHURA Biosciences initiates Phase 3 approval trial of IFx-2.0 in carcinoma
Premium
The Fly
TuHURA Biosciences initiates Phase 3 approval trial of IFx-2.0 in carcinoma
2M ago
HURA
TuHURA Biosciences Approves Merger and Share Increase
Premium
Company Announcements
TuHURA Biosciences Approves Merger and Share Increase
2M ago
8K
HURA
TuHURA Biosciences, Kineta stockholders approve merger and related proposals
PremiumThe Fly
TuHURA Biosciences, Kineta stockholders approve merger and related proposals
2M ago
HURA
KANT
TuHURA Biosciences initiated with a Buy at Brookline
PremiumThe Fly
TuHURA Biosciences initiated with a Buy at Brookline
2M ago
HURA
TuHURA Biosciences Approves Executive Salary Increases
PremiumCompany Announcements
TuHURA Biosciences Approves Executive Salary Increases
2M ago
8K
HURA
TuHURA announces FDA removed partial clinical hold on Phase 3 trial of IFx-2.0
PremiumThe Fly
TuHURA announces FDA removed partial clinical hold on Phase 3 trial of IFx-2.0
2M ago
HURA
TuHURA Biosciences Secures $12.6M for Strategic Initiatives
PremiumCompany AnnouncementsTuHURA Biosciences Secures $12.6M for Strategic Initiatives
2M ago
8K
HURA
TuHURA Biosciences: Promising Oncology Advancements and Strategic Acquisitions Drive Buy Rating
Premium
Ratings
TuHURA Biosciences: Promising Oncology Advancements and Strategic Acquisitions Drive Buy Rating
2M ago
HURA
TuHURA Biosciences announces $12.5M private placement
Premium
The Fly
TuHURA Biosciences announces $12.5M private placement
2M ago
HURA
Positive Outlook for TuHURA Biosciences: Strategic Initiatives and Upcoming Catalysts Support Buy Rating
PremiumRatings
Positive Outlook for TuHURA Biosciences: Strategic Initiatives and Upcoming Catalysts Support Buy Rating
3M ago
HURA
TuHURA Biosciences Amends Merger Agreement with Kineta
PremiumCompany Announcements
TuHURA Biosciences Amends Merger Agreement with Kineta
3M ago
8K
HURA
Innovative Immune Therapy Approach Drives Buy Rating for TuHURA Biosciences
PremiumRatings
Innovative Immune Therapy Approach Drives Buy Rating for TuHURA Biosciences
3M ago
HURA
TuHURA Biosciences initiates Phase 1b/2a study of IFx-Hu2.0 in carcinoma
PremiumThe Fly
TuHURA Biosciences initiates Phase 1b/2a study of IFx-Hu2.0 in carcinoma
3M ago
HURA
TuHURA Biosciences: Promising Developments in Anti-VISTA Antibody and DNA-based Immune Activator Justify Buy Rating
PremiumRatingsTuHURA Biosciences: Promising Developments in Anti-VISTA Antibody and DNA-based Immune Activator Justify Buy Rating
4M ago
HURA
TuHURA Biosciences and Kineta present updated results of cancer candidates
Premium
The Fly
TuHURA Biosciences and Kineta present updated results of cancer candidates
4M ago
HURA
KANT
TuHURA Biosciences price target lowered to $12 from $13 at H.C. Wainwright
Premium
The Fly
TuHURA Biosciences price target lowered to $12 from $13 at H.C. Wainwright
4M ago
HURA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >